Brainstorm Cell Therapeutics Inc.
BCLI- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001137883
No open-market purchases or sales by Brainstorm Cell Therapeutics Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Brainstorm Cell Therapeutics Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 43 | 2 | 48 | +7 |
| Shares | 3.70M | 12.8K | 6.36M | +2.67M (+72.6%) |
| Value | $6.16M | $21.0K | $20.4M | +$14.3M (+233.3%) |
2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Brainstorm Cell Therapeutics Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AIGH Capital Management LLC | 1,459,095 | $4.82M | 1.78% |
| Worth Venture Partners, LLC | 358,938 | $1.18M | 0.58% |
| Liberty Wealth Management LLC | 150,400 | $496.3K | 0.10% |
| Tru Independence Asset Management 2, LLC | 44,000 | $145.2K | 0.15% |
| Wolverine Trading, LLC | 26,979 | $67.0K | 0.00% |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 12,686 | $41.9K | 0.00% |
| XTX Topco Ltd | 12,227 | $40.3K | 0.01% |
| Raymond James Financial Services Advisors, Inc. | 11,248 | $37.1K | 0.00% |
| JPMorgan Chase & Co | 2,983 | $10.0K | 0.00% |
| FMR LLC | 400 | $1.32K | 0.00% |
| Piershale Financial Group, Inc. | 100 | $330 | 0.00% |
| Caldwell Sutter Capital, Inc. | 157,009 | $0 | 0.00% |
Sold out (5)
Institutions that held Brainstorm Cell Therapeutics Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| IFP Advisors, Inc | 26,650 | $139.0K |
| Marshall Wace, LLP | 37,582 | $61.6K |
| Janney Montgomery Scott LLC | 20,000 | $33.0K |
| Jane Street Group, LLC | 14,054 | $23.0K |
| Renaissance Technologies LLC | 11,800 | $19.0K |
Not filed for Q1 2023 yet (2)
Institutions that held Brainstorm Cell Therapeutics Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| S.C. Financial Services, Inc. | 12,686 | $20.8K |
| CoreCap Advisors, LLC | 133 | $218 |